↓ Skip to main content
Embed badge What is this page?

A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), Resistance Training followed by ingestion of essential amino acids high in leucine in…

Overview of attention for article published in BMC Cancer, November 2011
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
147 Mendeley

What is this page?

Summary Twitter Facebook Dimensions citations
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), Resistance Training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients - ACCeRT Study
Published in
BMC Cancer, November 2011
DOI 10.1186/1471-2407-11-493
Pubmed ID
22111896
Authors

Elaine S Rogers, Roderick D MacLeod, Joanna Stewart, Stephen P Bird, Justin WL Keogh

Abstract

Cancer cachexia is a syndrome of progressive weight loss. Non-small cell lung cancer patients experience a high incidence of cachexia of 61%. Research into methods to combat cancer cachexia in various tumour sites has recently progressed to the combination of agents.The combination of the anti-cachectic agent Eicosapentaenoic acid (EPA) and the cyclo-oxygenase-2 (COX-2) inhibitor celecoxib has been tested in a small study with some benefit. The use of progressive resistance training (PRT) followed by the oral ingestion of essential amino acids (EAA), have shown to be anabolic on skeletal muscle and acceptable in older adults and other cancer groups.The aim of this feasibility study is to evaluate whether a multi-targeted approach encompassing a resistance training and nutritional supplementation element is acceptable for lung cancer patients experiencing cancer cachexia.

View on publisher site

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 147 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 1%
United Kingdom 1 <1%
India 1 <1%
Canada 1 <1%
Unknown 142 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 27 18%
Student > Bachelor 22 15%
Researcher 17 12%
Student > Ph. D. Student 16 11%
Student > Postgraduate 12 8%
Other 32 22%
Unknown 21 14%
Readers by discipline Count As %
Medicine and Dentistry 51 35%
Nursing and Health Professions 27 18%
Agricultural and Biological Sciences 15 10%
Sports and Recreations 10 7%
Biochemistry, Genetics and Molecular Biology 4 3%
Other 13 9%
Unknown 27 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 March 2012.
All research outputs
#9,508,467
of 12,372,945 outputs
Outputs from BMC Cancer
#2,701
of 4,558 outputs
Outputs of similar age
#149,725
of 216,570 outputs
Outputs of similar age from BMC Cancer
#159
of 277 outputs
Altmetric has tracked 12,372,945 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,558 research outputs from this source. They receive a mean Attention Score of 3.9. This one is in the 33rd percentile – i.e., 33% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 216,570 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 277 others from the same source and published within six weeks on either side of this one. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.

This page is provided by Altmetric.